1 December 2022 false No description of principal activity Taxfiler 2023.14 11675683business:PrivateLimitedCompanyLtd2022-12-012023-11-30 116756832022-11-30 116756832022-12-012023-11-30 11675683business:AuditExempt-NoAccountantsReport2022-12-012023-11-30 11675683business:FilletedAccounts2022-12-012023-11-30 116756832023-11-30 11675683business:Director12022-12-012023-11-30 11675683business:RegisteredOffice2022-12-012023-11-30 116756832022-11-30 11675683core:WithinOneYear2023-11-30 11675683core:WithinOneYear2022-11-30 11675683core:ShareCapitalcore:PreviouslyStatedAmount2023-11-30 11675683core:ShareCapitalcore:PreviouslyStatedAmount2022-11-30 11675683core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-11-30 11675683core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-11-30 11675683core:PreviouslyStatedAmount2023-11-30 11675683core:PreviouslyStatedAmount2022-11-30 11675683business:SmallEntities2022-12-012023-11-30 11675683countries:EnglandWales2022-12-012023-11-30 11675683core:ComputerEquipment2022-12-012023-11-30 11675683core:ComputerEquipment2022-11-30 11675683core:ComputerEquipment2023-11-30 116756832021-12-012022-11-30 iso4217:GBP xbrli:pure
Company Registration No. 11675683 (England and Wales)
RADIOPHARMACY CONSULTING LIMITED Unaudited accounts for the year ended 30 November 2023
RADIOPHARMACY CONSULTING LIMITED Unaudited accounts Contents
Page
- 2 -
RADIOPHARMACY CONSULTING LIMITED Company Information for the year ended 30 November 2023
Director
Dr A Hall
Company Number
11675683 (England and Wales)
Registered Office
97 TAUNTON LANE COULSDON CR5 1SH UNITED KINGDOM
Accountants
Tax Data Ltd 4 Marlpit Lane Coulsdon Surrey CR5 2HA
- 3 -
RADIOPHARMACY CONSULTING LIMITED Statement of financial position as at 30 November 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
2,672 
3,562 
Current assets
Cash at bank and in hand
5,512 
4,880 
Creditors: amounts falling due within one year
(8,837)
(8,441)
Net current liabilities
(3,325)
(3,561)
Net (liabilities)/assets
(653)
1 
Capital and reserves
Called up share capital
150 
150 
Profit and loss account
(803)
(149)
Shareholders' funds
(653)
1 
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 14 March 2024 and were signed on its behalf by
Dr A Hall Director Company Registration No. 11675683
- 4 -
RADIOPHARMACY CONSULTING LIMITED Notes to the Accounts for the year ended 30 November 2023
1
Statutory information
RADIOPHARMACY CONSULTING LIMITED is a private company, limited by shares, registered in England and Wales, registration number 11675683. The registered office is 97 TAUNTON LANE, COULSDON, CR5 1SH, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
25% Reducing Balance
4
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 1 December 2022
7,790 
At 30 November 2023
7,790 
Depreciation
At 1 December 2022
4,228 
Charge for the year
890 
At 30 November 2023
5,118 
Net book value
At 30 November 2023
2,672 
At 30 November 2022
3,562 
5
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
Trade creditors
89 
- 
Taxes and social security
55 
250 
Loans from directors
7,853 
7,291 
Accruals
840 
900 
8,837 
8,441 
- 5 -
RADIOPHARMACY CONSULTING LIMITED Notes to the Accounts for the year ended 30 November 2023
6
Average number of employees
During the year the average number of employees was 1 (2022: 1).
- 6 -